Showing 241 - 260 of 1210 results
The need for a smaller, more transportable version of ANSTO’s 1500-litre atmospheric radon-222 monitor, and with a calibration traceable to the International System of Units, prompted the team to develop a 200-litre radon monitor that would meet those needs.
ANSTO today welcomed a significant Federal Government funding allocation to further safeguard the production of life-saving nuclear medicines in Australia.
ANSTO is proud to host the Shorebirds Competition for the fourth year. This unique environmental poster competition is free to enter and offers over $4000 in prizes (insert link to prizes button) for students and schools!
ANSTO’s nuclear medicine processing and distribution facility assembles, loads, tests and distributes a range of nuclear medicine products, including Mo-99. The Mo-99 is dispensed into an ANSTO radiopharmaceutical Gentech® Generator where it decays to Tc-99m.
With over 70 years of nuclear expertise, ANSTO offers expert education and training programs
ANSTO shared expertise on next-generation reactors and nuclear power with sustainable energy experts at the Australian Academy of Science symposium in May.
Detailed data on ANSTO electricity use and CO2 emissions for FY2022 - FY2023
Highlighting the contribution of four inspirational ANSTO leaders on International Women's Day.
An international team led by scientists at City University of Hong Kong has found flexible metal-organic framework (MOF) with one-dimensional channels that acts as a “molecular trapdoor” to selectively adsorb gases, such as carbon dioxide, in response to temperature and pressure changes.
The Japanese experience with leading-edge radiation treatment for cancer shows tremndous success
Lithium Australia, a company that has a close association with ANSTO’s business unit Minerals, has been awarded a US patent for its unique lithium mining technology SiLeach®.
Developed by ANSTO’s predecessor the Australian Atomic Energy Commission (known as the AAEC) in the late 1960s, the Technetium-99m Generator revolutionised nuclear medicine imaging in Australia by enabling imaging procedures to be performed not only in major capital cities but throughout regional and rural Australia.
ANSTO’s Innovation Precinct welcomes NSW Government’s $12.5 commitment funding.